Konan Medical
Generated 5/10/2026
Executive Summary
Konan Medical is a US-based ophthalmic diagnostics company founded in 2003 and headquartered in Irvine, California. It develops and commercializes innovative diagnostic devices for eye care professionals, focusing on objective perimetry, specular microscopy, color vision testing, and pupillometry. The company's products aim to enhance diagnostic precision and patient outcomes in ophthalmology. As a private company, Konan Medical operates in a growing market driven by an aging population and increasing prevalence of eye diseases. However, due to limited public financial information, its current market traction and valuation are uncertain. The company's long-standing presence since 2003 suggests a stable operational history, but without disclosed revenue or funding, growth prospects remain speculative.
Upcoming Catalysts (preview)
- Q3 2026Launch of next-generation perimetry device70% success
- H2 2026Strategic distribution partnership with a major ophthalmic network60% success
- 2027FDA 510(k) clearance for a new color vision diagnostic platform50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)